"As a community hospital, and as the most advanced medical facility for hundreds of miles, we are extremely committed to treating the medical needs of everyone who comes through our doors. We have provided generations of care in the Fairbanks community, and we look forward to continuing to make sure that your family is well taken care of, at all stages of their lives, for many years to come."

During the past decade, Fairbanks Memorial Hospital conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 39 clinical trials were completed, i.e. on average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 26 clinical trials were completed. i.e. 113% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fairbanks Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 60 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fairbanks Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Fairbanks Memorial Hospital" are "Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Fairbanks Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Fairbanks Memorial Hospital" are "Drug" (103 trials), "Other" (95 trials), "Biological" (62 trials), "Procedure" (41 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (36 trials), "Biospecimen Collection" (26 trials), "Questionnaire Administration" (25 trials) and "Computed Tomography" (23 trials). Other intervention names were less common.

The vast majority of trials in "Fairbanks Memorial Hospital" are 107 trials for "All" genders, 23 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Fairbanks Memorial Hospital". undefined are not yet recruiting, 41 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Fairbanks Memorial Hospital, 4 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Fairbanks Memorial Hospital, 1 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".